SCHEMBL23406401

SCHEMBL23406401

CC1(C)OB(c2c(Oc3ccccc3)cccc2Oc2cccc(Cl)c2)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A3 Q01959 2/20 0.46
LMNA P02545 1/20 0.43
RHEB Q15382 3/20 0.41
HTR1A P08908 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
HTR2A P28223 1/20 0.40
KCNH2 Q12809 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
ALOX12 P18054 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
DPP4 P27487 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23406341 0.96 SLC6A4 (0.46) SLC6A4SLC6A2SLC6A3LMNARHEB
SCHEMBL22159677 0.89 HTR2A (0.41) SLC6A4SLC6A2SLC6A3LMNACYP1A2
SCHEMBL16139819 0.89 LPL (0.43) SLC6A4SLC6A2LMNAALDH1A1KMT2A
SCHEMBL22159668 0.85 DPP4 (0.43) SLC6A4SLC6A2SLC6A3LMNAALDH1A1
SCHEMBL17423486 0.79 LIPG (0.46) MAPTLPLLIPGEGFR
SCHEMBL23406368 0.76 HTT (0.46) SLC6A4LMNACYP1A2MEN1MAPT
SCHEMBL121746 0.75 EGFR (0.42) SLC6A4SLC6A2SLC6A3RHEBHTR2A
SCHEMBL4356244 0.72 LPL (0.47) CYP1A2CYP2C9CYP2C19CYP3A4LPL
SCHEMBL1199141 0.72 LIPG (0.50) LPLLIPGPTGS1
SCHEMBL22400889 0.72 MEN1 (0.44) LMNACYP1A2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11600790-B2 Polycyclic aromatic compound for organic electroluminescent device KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2023-03-07 US disclosed
US-11600790-B2 Polycyclic aromatic compound for organic electroluminescent device KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2023-03-07 US disclosed
US-20210167288-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2021-06-03 US disclosed
US-20210167288-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2021-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210167288-A1 POLYCYCLIC AROMATIC COMPOUND ARNT, TYR, AHR SLC6A4 964/4885SLC6A2 1307/4885SLC6A3 1798/4885
US-11600790-B2 Polycyclic aromatic compound for organic electroluminescent device AOC2, TYR, BMI1 SLC6A4 1440/4885SLC6A2 1323/4885SLC6A3 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.